• Внутриутробное программирование здоровья женщины как детерминанта репродуктивного потенциала популяции
ru К содержанию

Внутриутробное программирование здоровья женщины как детерминанта репродуктивного потенциала популяции

HEALTH OF WOMAN. 2017.8(124):10–15; doi 10.15574/HW.2017.124.10  

Назаренко Л. Г., Нестерцова Н. С.
Харьковская медицинская академия последипломного образования
КУОЗ «Харьковский городской клинический родильный дом № 6»

Проанализирована взаимосвязь между массой тела женщин при рождении и развитием в будущем гинекологических заболеваний или отклонений в становлении репродуктивной системы, развитием онкологических заболеваний и сроков наступления менопаузы. Представлены результаты клинических исследований, проведенных в разное время в разных странах мира, которые освещают тему данной статьи.
Обзор мировой литературы, представленный в статье, обосновывает актуальность проведения соответствующих исследований в украинской популяции.
Ключевые слова: низкая масса тела при рождении, большая масса тела при рождении, гинекологическая патология.

Литература:

1. Хурасева А.Б. (2010). Репродуктивное здоровье женщин, родившихся с полярными значениями массы тела: Автореф. дис. … д-ра мед. наук: спец. 14.01.01 «Акушерство и гинекология». Волгоград: 10.

2. Barker DJ, Fall CH. 1993. Fetal and infant origins of cardiovascular disease. Arch Dis Child. 68(6):797–799. https://doi.org/10.1136/adc.68.6.797

3. Barker DJP et al. 2001. Size at birth and resilience to effects of poor living conditions in adult life: longitudinal study. BMJ. 323(7324):1273. https://doi.org/10.1136/bmj.323.7324.1273

4. Barclay DL. 1979. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies). J Ark Med Soc. 75(12):451–2. PMid:156173

5. Blush J et al. 2004. Estradiol reverses renal injury in Alb/TGF-beta1 transgenic mice. Kidney Int. 66:2148–2154. https://doi.org/10.1111/j.1523-1755.2004.66005.x; PMid:15569304

6. Bremer AA. 2010. Polycystic Ovary Syndrome in the Pediatric Population. Metab Syndr Relat Disord. 8(5):375–394. https://doi.org/10.1089/met.2010.0039; PMid:20939704 PMCid:PMC3125559

7. Cambonie G et al. 2007. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. American Journal of Physiology — Regulatory, Integrative and Comparative Physiology. 292(3):R1236-R1245 https://doi.org/10.1152/ajpregu.00227.2006

8. Calkins K, Sherin U Devaskar. 2011. Fetal Origins of Adult Disease. Curr Probl Pediatr Adolesc Health Care 41(6):158–176. https://doi.org/10.1016/j.cppeds.2011.01.001; PMid:21684471 PMCid:PMC4608552

9. Crain DA et al. 2008. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil Steril. 90(4):911–940. https://doi.org/10.1016/j.fertnstert.2008.08.067; PMid:18929049 PMCid:PMC4086418

10. Cresswell JL et al. 1997. Is the age of menopause determined in-utero? Early Hum Dev. 49(2):143–8. https://doi.org/10.1016/S0378-3782(97)00028-5

11. Davies MJ et al. 2012. Birthweight and thinness at birth independently predict symptoms of polycystic ovary syndrome in adulthood. Hum Reprod. 27(5):1475–80. https://doi.org/10.1093/humrep/des027; PMid:22373955

12. Fetal Nutrition and Adult Disease: Programming of Chronic Disease Through Fetal Exposure to Undernutrition. edited by Langley-Evans SC. Wallingford, UK: CABI. 2004. chapt. 11: Woods LL. Renal disease and fetal undernutrition: 235–258.

13. Goldberg JM, Falcone T. 1999. Effect of diethylstilbestrol on reproductive function. Fertil Steril. 72(1):1–7. https://doi.org/10.1016/S0015-0282(99)00153-3

14. Hales CN, Barker DJ. 2001. The thrifty phenotype hypothesis. Br Med Bull. 60:5–20. https://doi.org/10.1093/bmb/60.1.5

15. Hatch EE et al. 2006. Age at natural menopause in women exposed to diethylstilbestrol in utero. Am J Epidemiol. 164(7):682–8. https://doi.org/10.1093/aje/kwj257; PMid:16887893

16. Herbst AL, Ulfelder H, Poskanzer DC. 1971. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 284(15):878–81. https://doi.org/10.1056/NEJM197104222841604; PMid:5549830

17. Ibáñez L et al. 1998. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab. 83(10):3558–62. https://doi.org/10.1210/jc.83.10.3558; https://doi.org/10.1210/jcem.83.10.5205; PMid:9768664

18. Ibáñez L et al. 2007. Polycystic ovaries after precocious pubarche: relation to prenatal growth. Hum Reprod. 22(2):395–400. https://doi.org/10.1093/humrep/del395; PMid:17062583

19. Koziel S, Jankowska EA. 2002. Effect of low versus normal birthweight on menarche in 14-year-old Polish girls. J Paediatr Child Health 38(2):268–71. https://doi.org/10.1046/j.1440-1754.2002.00793.x; PMid:12047695

20. Lagiou P. 2006. Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand? Breast Cancer Res. 8(6):112. https://doi.org/10.1186/bcr1615; PMid:17118219 PMCid:PMC1797035

21. Li S et al. 2008. Low birth weight is associated with chronic kidney disease only in men. Kidney Int. 73(5):637–42. https://doi.org/10.1038/sj.ki.5002747; PMid:18094674

22. Mishra GD, Cooper R, Tom SE and Kuh D. 2009. Early life circumstances and their impact on menarche and menopause. Womens Health (Lond Engl). 5(2):175–190. https://doi.org/10.2217/17455057.5.2.175; PMid:19245355 PMCid:PMC3287288

23. Mumm H et al. 2013. Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991. Fertil Steril. 99(3):777–82. https://doi.org/10.1016/j.fertnstert.2012.11.004; PMid:23200688

24. Ojeda NB et al. 2007. Estrogen protects against increased blood pressure in post-pubertal female growth restricted offspring. Hypertension 50(4):679–685. https://doi.org/10.1161/HYPERTENSIONAHA.107.091785; PMid:17724277 PMCid:PMC2850594

25. Persson I et al. 1999. Influence of perinatal factors on the onset of puberty in boys and girls: implications for interpretation of link with risk of long-term diseases. Am J Epidemiol. 150(7):747–55. https://doi.org/10.1093/oxfordjournals.aje.a010077

26. Ravelli GP, Stein ZA, Susser MW. 1976. Obesity in young men after famine exposure in utero and early infancy. N Engl J Med. 295(7):349–53. https://doi.org/10.1056/NEJM197608122950701; PMid:934222

27. Rich-Edwards JW et al. 2005. Longitudinal study of birth weight and adult body mass index in predicting risk of coronary heart disease and stroke in women. BMJ. 330(7500):1115. https://doi.org/10.1136/bmj.38434.629630.E0

28. Dos Santos Silva I et al. 2002. Prenatal factors, childhood growth trajectories and age at menarche. Int J Epidemiol. 31(2):405–12. https://doi.org/10.1093/ije/31.2.405; https://doi.org/10.1093/intjepid/31.2.405; PMid:11980804

29. Treloar SA et al. 2000. Birth weight and age at menopause in Australian female twin pairs: exploration of the fetal origin hypothesis. Hum Reprod. 15(1):55–9. https://doi.org/10.1093/humrep/15.1.55; PMid:10611188

30. Vikström J et al. 2014. Birth characteristics in a clinical sample of women seeking infertility treatment: a case-control study. BMJ Open. 4(3):e004197. https://doi.org/10.1136/bmjopen-2013-004197; PMid:24613821 PMCid:PMC3963097

31. Woods LL, Ingelfinger JR, Rasch R. 2005. Modest maternal protein restriction fails to program adult hypertension in female rats. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology. 289(4): R1131-R1136 doi: 10.1152/ajpregu.00037.2003